Corrigendum to "Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program 'iTHER'" [Eur J Cancer 175 (2022) 311-325]

Karin P S Langenberg; Michael T Meister; Jette J Bakhuizen; Judith M Boer; Natasha K A van Eijkelenburg; Esther Hulleman; Uri Ilan; Eleonora J Looze; Miranda P Dierselhuis; Jasper van der Lugt; Willemijn Breunis; Linda G Schild; Kimberley Ober; Sander R van Hooff; Marijn A Scheijde-Vermeulen; Laura S Hiemcke-Jiwa; Uta E Flucke; Mariette E G Kranendonk; Pieter Wesseling; Edwin Sonneveld; Simone Punt; Arjan Boltjes; Freerk van Dijk; Eugene T P Verwiel; Richard Volckmann; Jayne Y Hehir-Kwa; Lennart A Kester; Marco M J Koudijs; Esme Waanders; Frank C P Holstege; H Josef Vormoor; Eelco W Hoving; Max M van Noesel; Rob Pieters; Marcel Kool; Miriam Stumpf; Mirjam Blattner-Johnson; Gnana P Balasubramanian; Cornelis M Van Tilburg; Barbara C Jones; David T W Jones; Olaf Witt; Stefan M Pfister; Marjolijn C J Jongmans; Roland P Kuiper; Ronald R de Krijger; Marc H W Wijnen; Monique L den Boer; C Michel Zwaan; Patrick Kemmeren; Jan Koster; Bastiaan B J Tops; Bianca F Goemans; Jan J Molenaar

doi:10.1016/j.ejca.2025.115423

Corrigendum to "Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program 'iTHER'" [Eur J Cancer 175 (2022) 311-325]

Eur J Cancer. 2025 May 15:221:115423. doi: 10.1016/j.ejca.2025.115423. Epub 2025 Apr 12.

Authors

Karin P S Langenberg¹, Michael T Meister², Jette J Bakhuizen³, Judith M Boer⁴, Natasha K A van Eijkelenburg⁴, Esther Hulleman⁴, Uri Ilan⁴, Eleonora J Looze⁴, Miranda P Dierselhuis⁴, Jasper van der Lugt⁴, Willemijn Breunis⁴, Linda G Schild⁴, Kimberley Ober⁴, Sander R van Hooff⁴, Marijn A Scheijde-Vermeulen⁵, Laura S Hiemcke-Jiwa⁵, Uta E Flucke⁵, Mariette E G Kranendonk⁵, Pieter Wesseling⁵, Edwin Sonneveld⁴, Simone Punt⁶, Arjan Boltjes⁴, Freerk van Dijk⁴, Eugene T P Verwiel⁴, Richard Volckmann⁷, Jayne Y Hehir-Kwa⁴, Lennart A Kester⁴, Marco M J Koudijs³, Esme Waanders³, Frank C P Holstege⁸, H Josef Vormoor⁹, Eelco W Hoving⁴, Max M van Noesel¹⁰, Rob Pieters⁴, Marcel Kool¹¹, Miriam Stumpf⁴, Mirjam Blattner-Johnson¹², Gnana P Balasubramanian¹², Cornelis M Van Tilburg¹³, Barbara C Jones¹³, David T W Jones¹², Olaf Witt¹³, Stefan M Pfister¹³, Marjolijn C J Jongmans⁴, Roland P Kuiper⁴, Ronald R de Krijger⁵, Marc H W Wijnen⁴, Monique L den Boer⁴, C Michel Zwaan⁴, Patrick Kemmeren⁸, Jan Koster⁷, Bastiaan B J Tops⁴, Bianca F Goemans⁴, Jan J Molenaar¹⁴

Affiliations

¹ Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: k.p.s.langenberg@prinsesmaximacentrum.nl.
² Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands; Oncode Institute, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands.
³ Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584 CX, the Netherlands.
⁴ Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands.
⁵ Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands; Department of Genetics, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584 CX, the Netherlands.
⁶ Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands; University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584 CX, the Netherlands.
⁷ Department of Oncogenomics, Center for Experimental and Molecular Medicine (CEMM), Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands.
⁸ Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands; Center for Molecular Medicine, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584 CX, the Netherlands.
⁹ Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands; Newcastle University, Newcastle Upon Tyne NE1 7RU, UK; Universitäts-Kinderspital Zürich, Steinwiesstrasse 75, Zürich 8032, Switzerland.
¹⁰ Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands; Division Imaging & Cancer, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584 CX, the Netherlands.
¹¹ Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Im Neuenheimer Feld, Heidelberg 69120, Germany.
¹² Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Im Neuenheimer Feld, Heidelberg 69120, Germany.
¹³ Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Im Neuenheimer Feld, Heidelberg 69120, Germany; Department of Pediatric Hematology and Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital, Im Neuenheimer Feld 430, Heidelberg 69120, Germany.
¹⁴ Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands; Department of Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, Utrecht 3584 CG, the Netherlands.

No abstract available

Publication types

Published Erratum